Bangladesh. Agricultural Biotechnology Annual. Sep 2014 Sept. 15, 2014
The biotechnology sector is in a nascent stage of development, but the government of Bangladesh (GOB) seeks to move forward in developing and commercializing agricultural biotechnology, such as Bt eggplant which was approved in 2013. The GOB has established a regulatory framework and approval process for all GE products developed domestically or by a third country.
The biotechnology sector is in a nascent stage of development, but the government of Bangladesh (GOB) seeks to move forward in developing and commercializing agricultural biotechnology, such as Bt eggplant which was approved in 2013. The Bangladesh Biosafety Rules (BR), 2012 and Biosafety Guidelines of Bangladesh (BG), 2007 officially created a regulatory framework and approval process for all GE products developed domestically or by a third country. GE products need to be approved before they can be imported or sold commercially within Bangladesh. Due to the information gap on agricultural biotechnology, disseminating information based on sound science will be critical to educate the public as new technologies are developed and commercialized.
CHAPTER 1: PLANT BIOTECHNOLOGY
PART A: PRODUCTION AND TRADE
a. Product Development
The Bangladesh Agricultural Research Institute (BARI) and Bangladesh Rice Research Institute (BRRI) are the only research institutions investing in developing genetically engineered (GE) products for commercial use. Although other Bangladeshi public sector research institutes and universities have biotechnology departments, government funding for biotechnology research is miniscule, and even that is operated by various ministries/institutions without any coordination at the national level.
BARI recently developed and received approval for Bt eggplant (brinjal) (see commercial section below). This project received support by USAID through the Agricultural Biotechnology Support Project II (ABSP II) and Mayco. Another GE crop developed by BARI (but not commercialized) includes two late blight resistant Bt potato varieties. After field trials and further toxicological testing, BARI noted that it plans to apply for product approval (see the Regulatory Framework section for further details on the approval process). Currently, the BRRI is developing a bacterial blight resistant rice called Dhan 29, as well as a submergence tolerant rice called Dhan 44. The Department of Biochemistry and Molecular Biology at the University of Dhaka has developed a salt tolerant rice. Some of these salt tolerant varieties are undergoing field trials.
b. Commercial Production:
In October 2013, four varieties of Bt eggplant seed were approved by the National Committee on Biosafety (NCB), which is located in the Ministry of Environment and Forests (MOEF). After approval, in early 2014, the government of Bangladesh GOB) distributed Bt eggplant seeds to 20 farmers. Currently, the crop is commercially grown on over two hectares and monitored by a Field Level Biosafety Committee that consists of officials from BARI, the Department of Agricultural Extension (DAE), Department of Environment (DOE), and local governments. Depending on the success of the small scale commercial production, sources believe that the seeds will be more widely distributed. The Bt eggplant produce can be sold in domestic markets.
According to sources, the GOB has not begun any third country application process in order to export Bt eggplant.
According to Bangladesh Biosafety Rules (BR), 2012, a GE product needs to be approved by the MOEF before it can be imported and commercially sold within Bangladesh (see Regulatory Framework section below). Post contacts noted that the Cotton Development Board is planning to seek approval for a Bt cotton variety for domestic cultivation.
e. Food Aid
Regarding the monetization of food aid, historically Bangladesh has imported conventional crops such as wheat.
PART B: POLICY
a. Regulatory Framework
The agricultural biotechnology sector in Bangladesh is in a nascent stage of development, but the national government seeks to move forward in developing and commercializing biotechnology. Bangladesh has published various regulations, policies, and other documents on biotechnology such as the National Biotechnology Policy, 2006, Biosafety Framework (NBF), 2007, Biosafety Guidelines of Bangladesh (BG), 2007, and BR, 2012.
The Guidelines for the Safety Assessment of Foods Derived from Genetically Engineered Plants was recently published in the last few years and allegedly is consistent with Codex standards. The document notes it was written to “provide technical guidance on the safety assessment process for whole foods, food products, and foods used as ingredients, that are derived from GE plant sources.” Sources state that the Bangladesh Standardization and Testing Institute (BSTI) has the lead in assessing the safety of GE foods derived from GE plants.
The National Task Force on Biotechnology Development (NTFBD), led by the Prime Minister of Bangladesh, is the apex body of five national-level biotechnology committees that provides final approval on all biotechnology-related policies. For example, the NTFBD approved the National Biotechnology Policy, 2006 and other ministry level policies, such as the BG, 2007. The five national-level biotechnology committees cover biodiversity, biosafety, crop biotechnology, livestock and fisheries biotechnology, and medical biotechnology. Among other functions, these national committees receive and review biotechnology applications.
Regarding the approval of imported and domestically developed GE products, an informal translation of the BR, 2012 notes that “The Ministry of Environment and Forests shall follow the [Environmental Conversation] Act and other concerned rules formulated under the Act, if any, and the provisions of the [Biosafety] Guidelines in case of issuing approval.” Moreover, the document states “an individual or a firm shall not import, export, buy, or sell any genetically modified organism or products or use them [without any approval from the Ministry of Environment and Forests].” Because Bangladesh is a signatory of the Cartagena Protocol on Biosafety (CP), the BG, 2007 closely follows the biotech application approval processes contained in the CP.
The MOEF is the lead ministry in charge of implementing the CP, and established the NCB as the final decision-making body on approving biotechnology applications. The NCB includes 21 members from various ministries such as the Ministry of Science and Technology, Ministry of Agriculture, Ministry of Fisheries and Livestock, and heads of national research institutes and departments. Other important committees include the: 1) Biosafety Core Committee (BCC), which provides the NCB with technical comments and recommendations on GE applications, and advises on other GE issues; 2) Institutional Biosafety Committee (IBC), which evaluates and monitors research and development activities in research institutions; and 3) Field Level Biosafety Committee (FBC), which monitors field trials for GE plants, animals, or fish.
Information on the biotechnology approval process can be found in section 3.1.8 of the BG, 2007, entitled “Procedures and Guidelines for Obtaining Permission in Favor of Working with GMOs.” GE applications are divided into three categories: 1) GE plants, animals, and fish; 2) GE products used for food, feed, or processing; and 3) laboratory research. Each category provides information on data requirements, field trials, or other provisions. Section 3.2.2 of the BG, 2007 provides some information on how many days it will take for a decision to be made on a biotechnology application from a third country. However, the overall timeline is unclear, and could be as long as 360 days, if not more.
Although the BG, 2007 does not provide much information on the step-by-step approval procedure, according to contacts, a technical committee will review the dossier and submit any recommendations or concerns to the NCB. Afterward, in most cases, the NCB will send the dossier to the BCC for further review and to recommend a decision. The NCB provides a final decision on the GE application. If approved, four copies of the permit will be issued (please see section 3.1.10 of the BG, 2007).
According to Post contacts, a biotech application can be submitted to the Secretary (chairman) of the NCB or to one of the Secretaries of a technical committee. Applications allegedly may be submitted at any time of the year. Reportedly, the NCB is in the process of developing application forms that will need to be filled out to complete the biotechnology application process.
After obtaining approval from the NCB, according to an informal translation of BR, 2012, “[the] application may be filed to the Ministry of Commerce or other concerned authorities to commercially import and export or use commercially under the existing import and export policies of the country.” Current import and export policies that regulate trade and may require additional approvals for GE products include: Import Policy Order 2012-15, Export Policy Order 2012-15, Plant Quarantine Rules, 1966 (amended up to 1989), and the Animal Quarantine Act, 2005.
Four varieties of Bt eggplant seed were developed by BARI and have been approved for limited scale commercial production. The varieties include: 1) Bt eggplant 1 (Bt Uttara); 2) Bt eggplant 2 (Bt Kajla); 3) Bt eggplant 3 (Bt Nayantara); and 4) Bt eggplant 4 (Bt ISD 006). Currently, no other biotech applications are pending.
c. Field Testing:
The National Technical Committee on Crop Biotechnology (NTCCB) or the National Technical Committee on Fisheries and Livestock Biotechnology (NTCFLB) give a recommendation to the NCB on whether to allow field testing for plants or animals. The FBC monitors the field trials and collects data during the biotechnology approval process.
d. Stacked Events:
No regulations exist at this time.
e. Additional Requirements:
Variety registration is required for approved GE seeds. According to the Seed Policy of Bangladesh, 1992, all plant varieties need to be registered with the National Seed Board (NSB) before commercial production. Except for controlled crops (rice, wheat, jute, potato and sugarcane), registration does not involve additional testing.
According to section 188.8.131.52 in BG, 2007, the country of export must certify that a GE product used for food, processing, or feed is “fit for consumption,” and either “does not contain harmful ingredients” or “is free from all kinds of harmful germs.” Moreover, the certificate should mention the ‘‘age group for which the item is eligible for consumption.’’
Currently, there are no specific regulations or policies that address coexistence.
An informal translation of BR, 2012 states ”The box or package carrying the Genetically Modified Organism or products shall bear the complete information of its identification on them or bear labeling that states that the product is Genetically Modified Organism or that has been produced from Genetically Modified Organism.” Additional requirements are specified in section 184.108.40.206 of the BG, 2007 and the Product Labeling Policy, 2006.
h. Trade Barriers:
BG, 2007 notes that an exporter or the country of export needs to apply for GE product approval. Because life science companies apply for GE product approval, it is unclear how to initiate the process in Bangladesh. Likewise, the requirement that a country of export must ensure there is legal requirement for the accuracy of biotech applications adds additional confusion. Labeling requirements and other certifications (see Additional Requirements) may also create challenges.
i. Intellectual Property Rights:
Bangladesh lacks effective legislation or enforcement mechanisms to protect intellectual property rights.
j. Cartagena Protocol Ratification
Bangladesh is a signatory to the Cartagena Protocol on Biosafety (CP). It ratified the protocol in 2004. The BR, 2012 and BG, 2007 create a framework to implement the CP.
k. International Treaties/Fora
Bangladesh is a member of International Plant Protection Convention (IPPC) and Codex Alimentarius (Codex). Activity in these two international bodies has been limited.
l. Related Issues:
m. Monitoring and testing:
On behalf of the NCB, the Field Level Biosafety Committee monitors approved GE crops and animals for performance and impact on biodiversity or the environment.
n. Low Level Presence:
Currently, there are no regulations or policies that address low level presence.
PART C: MARKETING
a. Market Acceptance:
Because there is a dearth of reliable information, many Bangladeshi citizens are not well informed. The quality of publically disseminated information is not always accurate or supported with sound science. Gaining future market acceptance will greatly depend on education efforts.
Bio-engineered seeds for planting may experience difficulty gaining market acceptability, unless apprehensions about multinational seed companies are addressed and prices reduced. The lack of purchasing power in the farming sector, due to the predominance of small and marginal farmers, may also restrict the wider use of biotech seeds, which farmers believe are higher priced vis-à-vis non-biotech varieties.
b. Public/Private Opinion:
There is a general recognition within Bangladesh’s scientific and policy community that biotechnology offers a tool to provide food security to the country’s growing population. Nevertheless, some local advocacy groups publicly question GE technology; in Fall 2013, according to the media, some of these groups legally challenged the GOB on whether it could release Bt eggplant.
c. Marketing Studies:
PART D: CAPACITY BUILDING AND OUTREACH
Since 2004, USAID has funded the Agricultural Biotechnology Support Project (ABSP II), which has provided technical assistance to BARI in developing new GE products. The ISAAA (International Service for the Acquisition of Agro-biotech Applications) and South Asia Biosafety Program (SABP) have a limited presence in Bangladesh.
b. Strategies and Need:
Due to the information gap on agricultural biotechnology, disseminating information based on sound science will be critical to educate the public on agricultural biotechnology as new technologies are developed and commercialized. In this regard, further education on risk communication may also be helpful.
CHAPTER 2: ANIMAL BIOTECHNOLOGY
PART E: PRODUCTION AND TRADE
Reportedly, Bangladesh has not conducted cloning or GE animal research. Since the private sector has no capacity to engage in genetic engineering or cloning, the only future possibility is for public sector research; the Bangladesh Livestock Research Institution may in the future undertake such research efforts. Bangladesh does not import or export any GE animals or animal products.
PART F: POLICY
BR, 2012 and BG, 2007 also apply for approving GE animal research, commercialization, and trade (see previous sections on Regulatory Framework, Field Testing, and Monitoring and Testing). The National Guidelines for Fish and Animal Biotechnology, 2006 establish objectives to promote: (i) acquisition of knowledge of and skills in animal and fish biotechnology and (ii) development of biotechnology tools in the fields of fisheries and livestock subject to optimum safety and acceptability.
PART G: MARKETING
Most Bangladeshis have little or no knowledge on GE animals. For Muslim majority conservative societies, public perception of animal biotechnology and cloning is likely to be sensitive